These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8180009)
1. CGP 55398, a liposomal Ge(IV) phthalocyanine bearing two axially ligated cholesterol moieties: a new potential agent for photodynamic therapy of tumours. Segalla A; Milanesi C; Jori G; Capraro HG; Isele U; Schieweck K Br J Cancer; 1994 May; 69(5):817-25. PubMed ID: 8180009 [TBL] [Abstract][Full Text] [Related]
2. Effect of axial ligation and delivery system on the tumour-localising and -photosensitising properties of Ge(IV)-octabutoxy-phthalocyanines. Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA Br J Cancer; 1995 Apr; 71(4):727-32. PubMed ID: 7710936 [TBL] [Abstract][Full Text] [Related]
3. Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl-phthalocyanine. Fabris C; Ometto C; Milanesi C; Jori G; Cook MJ; Russell DA J Photochem Photobiol B; 1997 Jul; 39(3):279-84. PubMed ID: 9253202 [TBL] [Abstract][Full Text] [Related]
5. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Reddi E; Zhou C; Biolo R; Menegaldo E; Jori G Br J Cancer; 1990 Mar; 61(3):407-11. PubMed ID: 2328207 [TBL] [Abstract][Full Text] [Related]
6. Effects of photodynamic therapy on the absorption properties of disulphonated aluminum phthalocyanine in tumor-bearing mice. Cubeddu R; Canti G; D'Andrea C; Pifferi A; Taroni P; Torricelli A; Valentini G J Photochem Photobiol B; 2001 Jul; 60(2-3):73-8. PubMed ID: 11470561 [TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetic and photodynamic studies with zinc(II) phthalocyanine in hamsters bearing an induced or transplanted rhabdomyosarcoma. Shopova M; Mantareva V; Krastev K; Hadjiolov D; Milev A; Spirov K; Jori G; Ricchelli F J Photochem Photobiol B; 1992 Oct; 16(1):83-9. PubMed ID: 1469513 [TBL] [Abstract][Full Text] [Related]
8. In vivo absorption spectrum of disulphonated aluminium phthalocyanine in a murine tumour model. Cubeddu R; Canti G; Musolino M; Pifferi A; Taroni P; Valentini G J Photochem Photobiol B; 1996 Jul; 34(2-3):229-35. PubMed ID: 8810541 [TBL] [Abstract][Full Text] [Related]
9. Effect of the delivery system on the biodistribution of Ge(IV) octabutoxy-phthalocyanines in tumour-bearing mice. Soncin M; Polo L; Reddi E; Jori G; Kenney ME; Cheng G; Rodgers MA Cancer Lett; 1995 Feb; 89(1):101-6. PubMed ID: 7882292 [TBL] [Abstract][Full Text] [Related]
10. In vivo absorption spectroscopy of tumor sensitizers with femtosecond white light. af Klinteberg C; Pifferi A; Andersson-Engels S; Cubeddu R; Svanberg S Appl Opt; 2005 Apr; 44(11):2213-20. PubMed ID: 15835366 [TBL] [Abstract][Full Text] [Related]
11. Relative contributions of apoptosis and random necrosis in tumour response to photodynamic therapy: effect of the chemical structure of Zn(II)-phthalocyanines. Jori G; Fabris C J Photochem Photobiol B; 1998 Jun; 43(3):181-5. PubMed ID: 9718718 [TBL] [Abstract][Full Text] [Related]
12. Tissue uptake, distribution, and potency of the photoactivatable dye chloroaluminum sulfonated phthalocyanine in mice bearing transplantable tumors. Chan WS; Marshall JF; Lam GY; Hart IR Cancer Res; 1988 Jun; 48(11):3040-4. PubMed ID: 3284641 [TBL] [Abstract][Full Text] [Related]
13. Photodynamic activities and biodistribution of fluorinated zinc phthalocyanine derivatives in the murine EMT-6 tumour model. Allémann E; Brasseur N; Kudrevich SV; La Madeleine C; van Lier JE Int J Cancer; 1997 Jul; 72(2):289-94. PubMed ID: 9219835 [TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of tumours with hexadecafluoro zinc phthalocynine formulated in PEG-coated poly(lactic acid) nanoparticles. Allémann E; Rousseau J; Brasseur N; Kudrevich SV; Lewis K; van Lier JE Int J Cancer; 1996 Jun; 66(6):821-4. PubMed ID: 8647656 [TBL] [Abstract][Full Text] [Related]
15. [Photodynamic therapy of zinc sulfonated phthalocyanine on murine transplanted tumors, its tissue distribution, and damaging effect on DNA of cancer cell]. Fu NW; Guo R; Yan LX; Huang L; Xu HJ Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):457-61. PubMed ID: 1819903 [TBL] [Abstract][Full Text] [Related]
16. Tumour-localising and -photosensitising properties of a novel zinc(II) octadecylphthalocyanine. Ometto C; Fabris C; Milanesi C; Jori G; Cook MJ; Russell DA Br J Cancer; 1996 Dec; 74(12):1891-9. PubMed ID: 8980387 [TBL] [Abstract][Full Text] [Related]
17. Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies. Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA Br J Cancer; 1990 Dec; 62(6):966-70. PubMed ID: 2257228 [TBL] [Abstract][Full Text] [Related]
18. Liposome-delivered 131I-labelled Zn(II)-phthalocyanine as a radiodiagnostic agent for tumours. Polo L; Segalla A; Jori G; Bocchiotti G; Verna G; Franceschini R; Mosca R; De Filippi PG Cancer Lett; 1996 Dec; 109(1-2):57-61. PubMed ID: 9020903 [TBL] [Abstract][Full Text] [Related]
19. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. Peng Q; Moan J Br J Cancer; 1995 Sep; 72(3):565-74. PubMed ID: 7669563 [TBL] [Abstract][Full Text] [Related]
20. Zn(II)-phthalocyanine as a photodynamic agent for tumours. II. Studies on the mechanism of photosensitised tumour necrosis. Milanesi C; Zhou C; Biolo R; Jori G Br J Cancer; 1990 Jun; 61(6):846-50. PubMed ID: 2372486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]